COVID Rounds: EU Episode 2

CME

COVID-19 in the EU: Inpatient Treatment of Mild to Moderate COVID-19 in Patients Who Are Immunocompromised

European Learners: 0.25 hours EBAC® effective education time

Released: February 06, 2025

Expiration: February 05, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Which therapy would you recommend for a person at high risk for COVID-19 progression who was admitted to the hospital with mild to moderate COVID-19 after their symptoms started 2 days prior?